The British government is studying finance use of weight loss medication so that unemployed people with obesity can return to the labor market. According to the Ministry of Health, Wes Streetingand which consider the use of Mounjaro injections – given to patients with diabetes– for about 250,000 people in the next three years. The goal is to save a lot 11,000 million euros The annual National Health Service (NHS) obesity prevention target is to reduce the number of people working age which is available not working in the United Kingdom, where there are more than 9 million people.
“Diseases caused by obesity cause people to take approx four more days a yearwhile many others are forced to quit their jobs,” he said. Walking the streets in an article published in the ‘Daily Telegraph’. “The long-term benefits of this drug could be huge in our fight against obesity.” “For many people, these weight loss injections will change their lives, help them get back to work and reduce the demands on our NHS,” he added. According to the latest NHS Health Survey in England, a 29% of adults English is obesewhile 64% are overweight.
Millionaire Money
Streeting’s opinion coincides with the announcement of the American pharmaceutical company Eli Lillywhich has pledged funds of 279 million (334 million euros) in “new ways to provide health care and care for people with obesity”, including study with 3,000 people to see if the provision of this medicine reduces the workload and if it helps to reduce the pressure of the overcrowded medical services. A lesson to be held between Manchester Health Innovation It is a Mounjaro weight loss injection that lasts for five years.
This type of medication is being used to “suppress appetite” in patients and promote weight loss.
Using this type of medicine, including Ozempic o Zipboundit is already sometimes carried out in British health institutions to treat diseases such as obesity or diabetes, always under medical supervision. Medicines – which mimic the hormone GLP-1 – reduces appetite and makes the patient feel full, but experts warn that it is not a magic solution and must be combined with good habits and exercise. Something that he himself has re-examined Walking the streetswho insisted that affected people should adopt a “very healthy lifestyle” and that the NHS “I don’t always pay the bill”.
Economic development
Without guaranteeing the implementation of the project, the measure has already criticized the treatment of patients in terms of savings for the public sector, leaving aside the aspect related to health and prevention. Since coming to power last July, the Prime Minister, Keir Starmeris based on economic growth and the budget level, something they want to achieve by reducing public money and returning millions of workers to the labor market.
“These drugs can be very important to our economy and health,” Starmer assured the BBC this Tuesday. “It will be very beneficial for people who want to lose weight and will allow more people to return to work. It is also very important for the NHS, because we need more money for health care and think differently“, he emphasized.
Opponents of the plan argue that patients are helped out of savings.
It remains to be seen whether the pharmaceutical industry will be able to meet their demands. great importancewhich has already caused a shortage of the drug in the United Kingdom, and whether the health service will have the right tools to manage the implementation of the program that requires hundreds of thousands of Britons.
